283 related articles for article (PubMed ID: 25261936)
1. Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.
Alonso-Alconada L; Muinelo-Romay L; Madissoo K; Diaz-Lopez A; Krakstad C; Trovik J; Wik E; Hapangama D; Coenegrachts L; Cano A; Gil-Moreno A; Chiva L; Cueva J; Vieito M; Ortega E; Mariscal J; Colas E; Castellvi J; Cusido M; Dolcet X; Nijman HW; Bosse T; Green JA; Romano A; Reventos J; Lopez-Lopez R; Salvesen HB; Amant F; Matias-Guiu X; Moreno-Bueno G; Abal M;
Mol Cancer; 2014 Sep; 13():223. PubMed ID: 25261936
[TBL] [Abstract][Full Text] [Related]
2. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.
Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M
Carcinogenesis; 2014 Dec; 35(12):2679-86. PubMed ID: 25233929
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer.
Mariscal J; Fernandez-Puente P; Calamia V; Abalo A; Santacana M; Matias-Guiu X; Lopez-Lopez R; Gil-Moreno A; Alonso-Alconada L; Abal M
J Proteome Res; 2019 Mar; 18(3):1043-1053. PubMed ID: 30585730
[TBL] [Abstract][Full Text] [Related]
4. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.
Bredemeier M; Edimiris P; Tewes M; Mach P; Aktas B; Schellbach D; Wagner J; Kimmig R; Kasimir-Bauer S
Oncotarget; 2016 Jul; 7(27):41677-41690. PubMed ID: 27223437
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
8. ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas.
Colas E; Muinelo-Romay L; Alonso-Alconada L; Llaurado M; Monge M; Barbazan J; Gonzalez M; Schoumacher M; Pedrola N; Ertekin T; Devis L; Ruiz A; Castellvi J; Doll A; Gil-Moreno A; Vazquez-Levin M; Lapyckyj L; Lopez-Lopez R; Robine S; Friederich E; Castro M; Reventos J; Vignjevic D; Abal M
Oncogene; 2012 Nov; 31(45):4778-88. PubMed ID: 22266854
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer.
Cierna Z; Mego M; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Cingelova S; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2014 Jun; 14():472. PubMed ID: 24972610
[TBL] [Abstract][Full Text] [Related]
10. TRP channel expression correlates with the epithelial-mesenchymal transition and high-risk endometrial carcinoma.
Van den Eynde C; De Clercq K; Van Bree R; Luyten K; Annibali D; Amant F; Han S; Van Nieuwenhuysen E; Baert T; Peeraer K; Voets T; Van Gorp T; Vriens J
Cell Mol Life Sci; 2021 Dec; 79(1):26. PubMed ID: 34936030
[TBL] [Abstract][Full Text] [Related]
11. Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.
Werner S; Stenzl A; Pantel K; Todenhöfer T
Adv Exp Med Biol; 2017; 994():205-228. PubMed ID: 28560676
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
14. Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress.
Hardingham JE; Grover P; Winter M; Hewett PJ; Price TJ; Thierry B
Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S25-31. PubMed ID: 26605644
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ
Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
Hamilton G; Rath B
Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
[TBL] [Abstract][Full Text] [Related]
17. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
18. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.
Kasimir-Bauer S; Hoffmann O; Wallwiener D; Kimmig R; Fehm T
Breast Cancer Res; 2012 Jan; 14(1):R15. PubMed ID: 22264265
[TBL] [Abstract][Full Text] [Related]
19. Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion.
Pedrola N; Devis L; Llauradó M; Campoy I; Martinez-Garcia E; Garcia M; Muinelo-Romay L; Alonso-Alconada L; Abal M; Alameda F; Mancebo G; Carreras R; Castellví J; Cabrera S; Gil-Moreno A; Matias-Guiu X; Iovanna JL; Colas E; Reventós J; Ruiz A
Clin Exp Metastasis; 2015 Jun; 32(5):467-78. PubMed ID: 25924802
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
